Provided by Tiger Trade Technology Pte. Ltd.

Illumina

219.40
+6.162.89%
Post-market: 220.901.50+0.68%19:55 EDT
Volume:1.92M
Turnover:416.69M
Market Cap:33.13B
PE:40.85
High:220.43
Open:212.40
Low:208.50
Close:213.24
52wk High:220.43
52wk Low:88.00
Shares:151.00M
Float Shares:147.89M
Volume Ratio:1.12
T/O Rate:1.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.37
EPS(LYR):5.45
ROE:32.34%
ROA:8.67%
PB:11.67
PE(LYR):40.26

Loading ...

GUIDANCE: (ILMN) Illumina Expects Fiscal 2026 Revenue Range $4.52B-$4.62B, vs. FactSet Est of $4.54B

MT Newswires Live
·
May 01

Illumina Q1 Adj. EPS $1.15 Beats $1.05 Estimate, Sales $1.090B Beat $1.073B Estimate

Benzinga Earnings
·
May 01

BRIEF-Illumina Q1 Adjusted EPS USD 1.15 Vs. IBES Estimate USD 1.05

Reuters
·
May 01

Illumina Outlook FY Total Revenue of $4.52-$4.62 Billion

THOMSON REUTERS
·
May 01

Illumina Inc - Board Authorizes Additional $1.5 Bln in Share Repurchases on April 28, 2026

THOMSON REUTERS
·
May 01

Illumina Q1 Adjusted EBIT Margin 21.9%

THOMSON REUTERS
·
May 01

Illumina Outlook FY Adjusted EPS USD 5.15-5.3

THOMSON REUTERS
·
May 01

Illumina Posts Higher 1Q Profit, Sales, Citing Growing Demand for NovaSeq X

Dow Jones
·
May 01

Stock Track | Illumina Soars 5.18% Intraday on Industry M&A Hopes and Patent Litigation

Stock Track
·
May 01

Illumina (ILMN) Valuation Check After DRAGEN v4.5 Launch And Pediatric Genomics Partnership

Simply Wall St.
·
Apr 27

Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive

Reuters
·
Apr 27

Did DRAGEN v4.5’s AI Genomics Push Just Shift Illumina’s (ILMN) Investment Narrative?

Simply Wall St.
·
Apr 26

Earning Preview: Illumina Q1 revenue is expected to increase by 4.12%, and institutional views are bearish

Earnings Agent
·
Apr 23

UPS, Netflix, BlackRock And A Health Care Stock On CNBC's 'Final Trades'

Benzinga
·
Apr 20

Illumina (ILMN) Valuation Check After DRAGEN v4.5 Launch And Major Pediatric Genomics Partnership

Simply Wall St.
·
Apr 18

Dragen V4.5 Supports Illumina's New Trupath Genome and 5-Base Assays, Drives Insights Across Germline, Oncology, and Multiomic Workflows

THOMSON REUTERS
·
Apr 16

BUZZ-Illumina to expand children's genetic disease research with new partnership, shares rise

Reuters
·
Apr 14

Illumina and D3b announce partnership for research in pediatric diseases

TIPRANKS
·
Apr 14

Illumina and the Center for Data-Driven Discovery in Biomedicine Bring Genomic Data and Scalable Software to the Fight Against Pediatric Cancer and Rare Disease

THOMSON REUTERS
·
Apr 14

Illumina Inc - Co and D3b Announce Data Partnership for Pediatric Cancer and Rare Disease Research

THOMSON REUTERS
·
Apr 14